Avanir Pharmaceuticals (AVNR) Misses Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts AVNR Hot Sheet
Price: $16.96 --0%
Financial Fact:
Revenues from royalties: 178.79K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Revenues from royalties: 178.79K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Avanir Pharmaceuticals (NASDAQ: AVNR) reported Q1 EPS of ($0.09), $0.01 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $16.5 million, versus $7.2 million reported last year.
For earnings history and earnings-related data on Avanir Pharmaceuticals (AVNR) click here.
For earnings history and earnings-related data on Avanir Pharmaceuticals (AVNR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- BofA maintains underperform ratings on six BDC stocks
- Arena Group to rename as Paradium.AI, ticker changing to PAAI
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
